| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 52,821 | 58,321 | 66,050 | 74,613 | | Cost of Revenue | 11,083 | 18,242 |
-
| 10,050 | | | Gross Profit | 41,738 | 40,079 | 66,050 | 64,563 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,430 | (1,625) | 18,191 | 23,708 | | Non Recurring | 49,836 |
-
|
-
| (13,963) | | Others | (34,396) | 18,685 | 16,237 | 56,817 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,868 | 23,019 | 31,622 | (1,999) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 21,868 | 23,019 | 31,622 | (1,999) | | Interest Expense | 26,175 | 28,972 | 32,131 | 35,301 | | Income Before Tax | (4,307) | (5,953) | (509) | (37,300) | | Income Tax Expense |
-
|
-
|
-
| (13,932) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,307) | (5,953) | (509) | (23,368) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,307) | (5,953) | (509) | (23,368) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,307) | ($5,953) | ($509) | ($23,368) |
|
0.31% Nasdaq 0.00%
Income Statement
